Brief: Galecto Inc- As Of Dec 31, 2020 Co's Cash, Cash Equivalents And Investments Balance Was About $164 Mln
Jan 5 (Reuters) - Galecto Inc GLTO.O :
* GALECTO, INC. - AS OF DEC31, 2020 CO'S CASH, CASH
EQUIVALENTS
AND INVESTMENTS BALANCE WAS ABOUT $164 MILLION
Source text: https://bit.ly/3nfjqzv
Further company coverage: GLTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Damora Therapeutics
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. RESEARCH ROUNDUP-Blackstone, Hartford Insurance, Zevra Therapeutics
U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology
Brief: Damora Therapeutics Reports First Quarter 2026 Financial Results
Brief: Damora Therapeutics: Lori Firmani To Cease Serving As CFO Effective May 1, 2026 - SEC Filing